‹ All stocks
IceCure Medical Ltd
ICCM · NASDAQ · Healthcare
$1.59
— $1.59 (0.00%)
Day range
$1.57 – $1.70
Year range
$1.56 – $33.00
Open
$1.59
Previous close
—
Market cap
$3.58M
Volume (24h)
$18.1K
Volume (52w)
$28.84K
Performance
7D
▼ -2.45%
1M
▼ -28.05%
3M
▼ -61.96%
6M
▼ -84.30%
1Y
▼ -94.70%
YTD
▼ -91.59%
3Y
▼ -93.95%
5Y
▼ -99.26%
All-time
▼ -99.51%
Key statistics
P/E ratio
-0.23
EPS (TTM)
$-6.94
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
2.3M
About IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1143.12 | -0.59% |
JNJ Johnson & Johnson |
$252.93 | -2.22% |
ABBV AbbVie |
$265.76 | 2.20% |
MRK Merck & Co. |
$139.54 | -2.97% |
UNH UnitedHealth Group Incorp… |
$378.58 | 3.66% |